BioSpace News Archive

ANI Pharmaceuticals, Inc. today announced that the Company will release its first quarter 2023 financial results on Monday, May 8, 2023, prior to the market open.

Intercept Pharmaceuticals, Inc. announced that seven abstracts in PBC and NASH have been accepted for presentation at EASL 2023.

TELA Bio, Inc. (“TELA Bio”) (NASDAQ: TELA) today announced that the company will report first quarter 2023 financial results on Thursday, May 11, 2023.

Annovis Bio announced that the United States Patent and Trademark Office has granted the Company a patent with claims covering the use of Annovis Bio’s lead drug candidate, buntanetap, for the prevention and treatment of diseases caused by the disruption in heavy metal homeostasis.

Tiziana Life Sciences Ltd. today announced broad-based findings on the utility of nasal anti-CD3 mAb in the treatment of intracerebral hemorrhage (ICH). The data using a mouse model of collagenase-induced ICH was presented at the Annual American Academy of Neurology conference.

Enzolytics, Inc. (OTC announces its continuing progress with the recently announced business combination between Enzolytics’ operating subsidiaries, Biogenysis and Virogentics, and Sagaliam Acquisition Corp.

Marinus Pharmaceuticals, Inc. today announced that it plans to release financial results for the first quarter ended March 31, 2023 on May 11, 2023.

Starton Therapeutics, Inc. and Healthwell Acquisition Corp. today announced that they have entered into a definitive business combination agreement (the “Business Combination Agreement”) pursuant to which, among other things, HWEL Holdings Corp., a newly formed wholly-owned subsidiary of Healthwell (“Pubco”), has agreed to acquire Starton and become a publicly traded company (the “Transaction”).

Bristol Myers Squibb (NYSE:BMY) today reports results for the first quarter of 2023, which reflect robust in-line and new product portfolio growth, strong commercial execution and continued advancement of the product pipeline.

BridgeBio Pharma, Inc. today announced that members of its management team will present at the Bank of America Merrill Lynch Global Healthcare Conference in Las Vegas, NV on Wednesday, May 10 at 10:00 am PT.